USPTO serial 79397997
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew J. Snider
Matthew J. Snider Dickinson Wright PLLC1825 Eye St., N.W., Suite 900Washington, DC 20006United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and biotechnological preparations and substances being pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; drug delivery agents consisting of compounds, namely, liposomes and viral particles that facilitate delivery of a wide range of pharmaceuticals | ACTIVE | — |
| 010 | Medical instruments and apparatus for use in surgery; medical instruments and apparatus, namely, clamps for surgical use, surgical retractors, surgical platforms, surgical stabilizers, and surgical manipulator arms; medical diagnostic instruments and apparatus for the diagnosis of neurological diseases and disorders, sold without medication; medical instruments and apparatus for administering pharmaceutical and biotechnological preparations and substances, sold without medication; medical instruments and apparatus for administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological diseases and disorders, sold without medication; implantable drug delivery devices, namely, implantable drug delivery pumps and implantable drug delivery ports | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the fields of medicine, health, healthcare, wellbeing, clinical trials, pharmaceuticals, biotechnology, biotechnological preparations and substances, gene therapy, neurosurgery, medical imaging, medical and scientific instruments and apparatus, neurology, and neurological, neuromuscular and neurodegenerative therapeutics, diseases and disorders; design and development of computer hardware and software; scientific research and development, biological research and development, clinical research and development, medical research and development; research, development and testing relating to pharmaceutical and biotechnological preparations and substances; research, development and testing relating to medical and scientific instruments and apparatus; research, development and testing relating to neurological therapeutics, diseases and disorders; design and development of medical diagnostic apparatus; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical and biotechnological preparations and substances; scientific research in the nature of conducting clinical trials for others in the fields of neurological therapeutics, diseases and disorders; scientific research in the nature of conducting clinical trials for others in the fields of medical and scientific instruments and apparatus; providing online, non-downloadable software for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention, diagnosis and treatment of neurological and neuromuscular diseases and disorders; providing online, non-downloadable software for analysing clinical information; providing online, non-downloadable software for diagnosis of neurological diseases and disorders; providing online, non-downloadable software for operating medical instruments and apparatus; providing online, non-downloadable software for connecting machines and medical instruments and apparatus; providing online, non-downloadable software for collecting and exchanging information and data; providing online, non-downloadable software for monitoring medical instruments and apparatus and interfacing with the cloud; providing online, non-downloadable software for mobile devices, smartphones, tablet computers, personal computers and televisions for use in developing, testing and administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological and neuromuscular diseases and disorders; providing online, non-downloadable software for transmitting, sharing, receiving, streaming, downloading, playing, organizing, displaying, collecting and transferring information, data, audio, video, images, content and other multimedia content between devices via the internet, over a wireless network and other communications networks; providing online, non-downloadable software for the remote control of machines and medical instruments and apparatus; providing online, non-downloadable software for facilitating cloud computing services; information technology services, namely, technical consulting services relating to the technology fields of medical and scientific instruments and apparatus; information technology services, namely, technical consulting services relating to the technology fields of pharmaceutical and biotechnological preparations and substances; advisory and consulting services related to the aforegoing services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 1, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 17, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 17, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 5, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 19, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 19, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 20, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 20, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 20, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 1, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 1, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 10, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 10, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 14, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 7, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 16, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 14, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 13, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 9, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 21, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 21, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 20, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |